(Q40300950)

English

Augmentation of the in vitro humoral immune response by pharmacologic agents. II: Comparison of the effects of antiproliferative agents with DBcAMP

scientific article published on March 1, 1979

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Augmentation of the in vitro humoral immune response by pharmacologic agents. II: Comparison of the effects of antiproliferative agents with DBcAMP (English)

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

5 June 2022

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

5 June 2022

author name string

S. W. Burchiel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A233583

5 June 2022

K. L. Melmon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A233583

5 June 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=233583

5 June 2022

publication date

1 March 1979

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0162310979900511?httpAccept=text/xml

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

5 June 2022

https://api.elsevier.com/content/article/PII:0162310979900511?httpAccept=text/plain

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

5 June 2022

Immunopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

151-163

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

1

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

5 June 2022

Modulation of inflammation and immunity by cyclic AMP.

0 references

Augmentation of the in vitro humoral immune response by pharmacologic agents. I: An explanation for the differential enhancement of humoral immunity via agents that elevate cAMP

5

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Enhancement of antibody formation by whole body x-radiation

9

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Cell populations and cell proliferation in the in vitro response of normal mouse spleen to heterologous erythrocytes. Analysis by the hot pulse technique

11

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Chemical suppression of adaptive immunity

13

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Enhancement of the PGE1 response of macrophages by concanavalin A and colchicine

14

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Colchicine potentiates β-adrenoreceptor-stimulated cyclic AMP in lymphoma cells by an action distal to the receptor

17

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide

20

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.

21

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Immunization of dissociated spleen cell cultures from normal mice

23

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Cellular requirements for the primary in vitro antibody response to DNP-ficoll

25

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Cyclic AMP levels in fibroblasts: relationship to growth rate and contact inhibition of growth.

26

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Role of Cyclic Nucleotides in Growth Control

27

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity

28

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Effects of colchicine on cyclic AMP levels in human leukocytes

30

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Inhibition of cell growth in vitro by adenosine 3',5'-monophosphate

31

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Effect of colchicine on the antibody response. I. Enhancement of antibody formation in mice

35

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Effect of colchicine on the antibody response. II. Demonstration of the inactivation of suppressor cell activities by colchicine

36

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin

38

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Rise and Fall of Cyclic AMP Required for Onset of Lymphocyte DNA Synthesis

42

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells

43

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

The involvement of cyclic nucleotide metabolism in the initiation of lymphocyte proliferation induced by mitogens

44

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Adenosine 3':5'-monophosphate content and actions in the division cycle of synchronized HeLa cells

46

1 reference

10.1016/0162-3109(79)90051-1

https://api.crossref.org/works/10.1016/0162-3109(79)90051-1

20 January 2023

Identifiers

10.1016/0162-3109(79)90051-1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40300950&oldid=1815407462"